Chicago (franchise)

Lara Lickhalter Joins Wilson Elser as a Partner in Chicago

Retrieved on: 
Tuesday, April 25, 2023

NEW YORK, April 25, 2023 /PRNewswire/ -- National law firm Wilson Elser announced today that Lara Lickhalter has joined the firm as a partner in its Transportation Practice in the Chicago office, effective April 18.

Key Points: 
  • NEW YORK, April 25, 2023 /PRNewswire/ -- National law firm Wilson Elser announced today that Lara Lickhalter has joined the firm as a partner in its Transportation Practice in the Chicago office, effective April 18.
  • "We are pleased to welcome Lara to the firm and the Chicago office," said Chicago Partner Loren Cohen.
  • Curt Schlom, Regional Managing Partner of the Chicago office, also cited Lickhalter's significant litigation and trial experience as one of the reasons Wilson Elser hired her as a lateral partner.
  • Lickhalter was previously a partner in the Chicago Transportation Practice Group of a law firm with a presence throughout the Midwest.

AltruBio Announces Poster Presentation on Immune Checkpoint Enhancer, ALTB-168 at Crohn’s & Colitis Congress 2023

Retrieved on: 
Thursday, January 19, 2023

The poster being presented on-site by Dr. Rubin will provide data on the Phase 2 open label study of ALTB-168 (neihulizumab) in patients with moderately to severely active anti-TNFα and/or anti-integrin refractory ulcerative colitis (UC).

Key Points: 
  • The poster being presented on-site by Dr. Rubin will provide data on the Phase 2 open label study of ALTB-168 (neihulizumab) in patients with moderately to severely active anti-TNFα and/or anti-integrin refractory ulcerative colitis (UC).
  • “With more than three million people in the U.S. suffering from inflammatory bowel disease, there remains a significant unmet need for novel therapies to achieve sustained remission,” said Dr. Rubin.
  • In the 8+2 regimen, among 14 enrolled subjects, 7 (50%) subjects achieved clinical response and 29% achieved clinical remission at Week 12.
  • Details about the poster presentation are as follows:
    Title: A Phase II Open Label Study of Neihulizumab, an anti-CD162 (PSGL-1 ) antibody, in patients with moderate to severe active, anti-TNFα and/or anti-integrin refractory ulcerative colitis
    For more information and to register for the Crohn’s & Colitis Congress 2023, visit the conference website .

J.F. Lehman & Company Announces Recent Promotions and New Hires

Retrieved on: 
Thursday, January 19, 2023

Lehman & Company ("JFLCO"), a leading middle-market private equity firm focused exclusively on the aerospace, defense, maritime, government and environmental sectors, is pleased to announce several recent promotions and new hires.

Key Points: 
  • Lehman & Company ("JFLCO"), a leading middle-market private equity firm focused exclusively on the aerospace, defense, maritime, government and environmental sectors, is pleased to announce several recent promotions and new hires.
  • "This talented group of professionals has made many meaningful contributions to our growing organization in recent years," said Louis N. Mintz, Partner.
  • "Their promotions are well-deserved and we're confident Michael, Tyler, Alfred and Bridget will continue to grow in their new and expanded roles."
  • "Collectively, these new hires reflect the firm's demonstrated ability to attract high caliber talent from leading organizations and foster a culture of shared success."

J.F. Lehman & Company Announces Recent Promotions and New Hires

Retrieved on: 
Thursday, January 19, 2023

Lehman & Company ("JFLCO"), a leading middle-market private equity firm focused exclusively on the aerospace, defense, maritime, government and environmental sectors, is pleased to announce several recent promotions and new hires.

Key Points: 
  • Lehman & Company ("JFLCO"), a leading middle-market private equity firm focused exclusively on the aerospace, defense, maritime, government and environmental sectors, is pleased to announce several recent promotions and new hires.
  • "This talented group of professionals has made many meaningful contributions to our growing organization in recent years," said Louis N. Mintz, Partner.
  • "Their promotions are well-deserved and we're confident Michael, Tyler, Alfred and Bridget will continue to grow in their new and expanded roles."
  • "Collectively, these new hires reflect the firm's demonstrated ability to attract high caliber talent from leading organizations and foster a culture of shared success."

Amanda DeGiorgi joins HNTB as program manager for bus and rail transit

Retrieved on: 
Thursday, January 19, 2023

BOSTON, Jan. 19, 2023 /PRNewswire-PRWeb/ -- Amanda DeGiorgi has joined HNTB as a program manager in the firm's Boston office, where she brings more than seven years of experience in the transit industry primarily working with the Massachusetts Bay Transportation Authority. DeGiorgi will serve as HNTB's deputy program manager for the MBTA's Mattapan High-Speed Line Transformation Program. In this role, DeGiorgi oversees planning and early design for the light rail corridor's modernization. The project includes implementing state-of-good repair, accessibility and safety improvements on all infrastructure, as well as upgrades that will allow future deployment of a modern light rail vehicle.

Key Points: 
  • BOSTON, Jan. 19, 2023 /PRNewswire-PRWeb/ -- Amanda DeGiorgi has joined HNTB as a program manager in the firm's Boston office, where she brings more than seven years of experience in the transit industry primarily working with the Massachusetts Bay Transportation Authority.
  • DeGiorgi will serve as HNTB's deputy program manager for the MBTA's Mattapan High-Speed Line Transformation Program.
  • In this role, DeGiorgi oversees planning and early design for the light rail corridor's modernization.
  • "Amanda is a trusted and valued partner to MBTA, bringing extensive expertise in all facets of bus and rail transit operations, planning and program management," said Gary Bua, HNTB senior vice president and Massachusetts office leader.

KATE GUELICH NAMED PRESIDENT OF MANAGEMENT CONSULTING

Retrieved on: 
Thursday, January 19, 2023

CHICAGO, Jan. 19, 2023 /PRNewswire/ -- Kaufman Hall has appointed Kate Guelich to president of its extensive management consulting operations, effective Jan. 1, 2023.

Key Points: 
  • CHICAGO, Jan. 19, 2023 /PRNewswire/ -- Kaufman Hall has appointed Kate Guelich to president of its extensive management consulting operations, effective Jan. 1, 2023.
  • In this role, Guelich will oversee the firm's Strategy, Financial Planning, Partnerships, Mergers and Acquisitions, Performance Improvement, Treasury and Capital Markets, and Clinical Documentation Improvement practices.
  • Guelich previously served as managing director of Kaufman Hall's Strategic Financial Planning practice, and is a member of the Kaufman Hall Board of Directors.
  • "We are confident that she will be a tremendous success in this new role as she applies her well-developed skills for smart consulting, analysis, management and being ahead of trends."

M&T Bank Corporation Elects Carlton J. Charles to Board of Directors

Retrieved on: 
Wednesday, January 18, 2023

BUFFALO, N.Y., Jan. 18, 2023 /PRNewswire/ -- M&T Bank Corporation (NYSE: MTB) ("M&T") announced today the election of Carlton J. Charles, Senior Vice President, Treasury and Risk Management at Hearst, to its Board of Directors, effective January 18, 2023.

Key Points: 
  • BUFFALO, N.Y., Jan. 18, 2023 /PRNewswire/ -- M&T Bank Corporation (NYSE: MTB) ("M&T") announced today the election of Carlton J. Charles, Senior Vice President, Treasury and Risk Management at Hearst, to its Board of Directors, effective January 18, 2023.
  • Upon his election, Mr. Charles was appointed as a member of the Nomination and Governance Committee of M&T's Board.
  • Mr. Charles was also elected to the Board of Directors of M&T Bank, M&T's principal banking subsidiary.
  • Mr. Charles serves on the Hearst Board of Directors and the Board of Advisors for HearstLab, Hearst's platform for nurturing the growth of early-stage, women-led companies.

Amrish T. Patel, MD, is recognized by Continental Who's Who

Retrieved on: 
Thursday, January 12, 2023

MARIETTA, Ga., Jan. 12, 2023 /PRNewswire/ -- Amrish T. Patel, MD, is being recognized by Continental Who's Who as a Top Pinnacle Professional as an orthopedic surgeon specializing in hand and upper extremity surgery.

Key Points: 
  • MARIETTA, Ga., Jan. 12, 2023 /PRNewswire/ -- Amrish T. Patel, MD, is being recognized by Continental Who's Who as a Top Pinnacle Professional as an orthopedic surgeon specializing in hand and upper extremity surgery.
  • He moved to Houston and earned his Bachelor of Science degree in mechanical engineering from Rice University.
  • Dr. Patel is a member of the American Academy of Orthopedic Surgery and the American Society for Surgery of the Hand.
  • The doctor would like to acknowledge his mentors: Daniel Mass, MD, and the owner of this practice, Viral Kumar Patel, MD.

Former ASTHO President Nirav D. Shah, MD, JD, Tapped as Principal Deputy Director for CDC

Retrieved on: 
Thursday, January 12, 2023

In partnership with ASTHO's Board of Directors, he led ASTHO through one of the organization's most challenging periods: the COVID-19 pandemic.

Key Points: 
  • In partnership with ASTHO's Board of Directors, he led ASTHO through one of the organization's most challenging periods: the COVID-19 pandemic.
  • Shah also played a key role shaping national COVID-19 policy through frequent meetings with other state leaders and federal officials.
  • I cannot think of a better person to serve as the CDC's next principal deputy director," says Michael Fraser, PhD, ASTHO CEO.
  • Shah has served as director of the Maine CDC since June 2019 and currently serves on the ASTHO board of directors.

Myron Scholes Named S. Donald Sussman Award Recipient by MIT Sloan School of Management

Retrieved on: 
Thursday, January 12, 2023

CAMBRIDGE, Mass., Jan. 12, 2023 /PRNewswire/ -- The MIT Sloan School of Management recently announced that Myron Scholes, Frank E. Buck Professor of Finance, Emeritus, at the Stanford Graduate School of Business, Nobel Laureate in Economic Sciences, and co-originator of the Black-Scholes/Merton option pricing model, was named the recipient of the S. Donald Sussman Award for the 2023–2024 academic year.The honor is awarded to individuals or groups who best exemplify S. Donald Sussman's career as a successful investor in quantitative investment strategies and models. Scholes was selected for his path breaking contributions to this field, as well as his research focused on understanding uncertainty and its effect on asset prices and the value of options.

Key Points: 
  • CAMBRIDGE, Mass., Jan. 12, 2023 /PRNewswire/ -- The MIT Sloan School of Management recently announced that Myron Scholes , Frank E. Buck Professor of Finance, Emeritus, at the Stanford Graduate School of Business , Nobel Laureate in Economic Sciences, and co-originator of the Black-Scholes/Merton option pricing model, was named the recipient of the S. Donald Sussman Award for the 2023–2024 academic year.
  • "Myron Scholes captures the essence of the Sussman Award as a finance scholar of the highest caliber who has also taken theory into investment practice successfully on multiple occasions," said MIT Sloan professor Andrew Lo , director of MIT Sloan's Laboratory for Financial Engineering, and a member of the award committee.
  • "I am excited to return to MIT Sloan to receive the Sussman Award.
  • Scholes continued his academic career with faculty positions at the University of Chicago Booth School of Business and Stanford University.